Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · see citing works

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · see citing works

Neuroinflammation in Alzheimer's disease

Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226 · see citing works

The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease

Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,630 · see citing works

Signaling to NF-κB by Toll-like receptors

Kawai, T., & Akira, S. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.09.002 · Cited by 2,395 · see citing works

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851 · see citing works

Microbiota-Brain-Gut Axis and Neurodegenerative Diseases

Quigley, E. M. M. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0802-6 · Cited by 804 · see citing works

Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation

Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772 · see citing works

Evidence for a cytokine model of cognitive function

McAfoose, J., & Baune, B. T. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.10.005 · Cited by 760 · see citing works

Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation

Petra, A. I., Panagiotidou, S., Hatziagelaki, E., Stewart, J. M., Conti, P., & Theoharides, T. C. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.04.002 · Cited by 592 · see citing works

Amyloid-Beta: A Crucial Factor in Alzheimer's Disease

Sadigh‐Eteghad, S., Sabermarouf, B., Majdi, A., Talebi, M., Farhoudi, M., & Mahmoudi, J. (2014) · Medical Principles and Practice · doi:10.1159/000369101 · Cited by 542 · see citing works

Clearing the brain's amyloid cobwebs

Selkoe, D. J. (2001) · Neuron · doi:10.1016/s0896-6273(01)00475-5 · Cited by 541 · see citing works

Toll-like receptor signaling in neural plasticity and disease

Okun, E., Griffioen, K. J. S., & Mattson, M. P. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.02.005 · Cited by 513 · see citing works

Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease

Pistollato, F., Sumalla Cano, S., Elio, I., Masias Vergara, M., Giampieri, F., & Battino, M. (2016) · Nutrition Reviews · doi:10.1093/nutrit/nuw023 · Cited by 496 · see citing works

Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula

Xu, J. Y., Lian, F., Zhao, L., Zhao, Y., Chen, X., Zhang, X., Guo, Y., Zhang, C., Zhou, Q., Xue, Z., et al. (2014) · The ISME Journal · doi:10.1038/ismej.2014.177 · Cited by 423 · see citing works

Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks

Harrison, F. E., Hosseini, A. H., & McDonald, M. P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.015 · Cited by 399 · see citing works

Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4

Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380 · see citing works

LPS-induced Murine Neuroinflammation Model: Main Features and Suitability for Pre-clinical Assessment of Nutraceuticals

Catorce, M. N., & Gevorkian, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151204122017 · Cited by 361 · see citing works

Microbiota regulation of the mammalian gut-brain axis

Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300 · see citing works

Gut-Brain Cross-Talk in Metabolic Control

Clemmensen, C., Müller, T. D., Woods, S. C., Berthoud, H., Seeley, R. J., & Tschöp, M. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.025 · Cited by 296 · see citing works

Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases

Hölscher, C. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0221 · Cited by 294 · see citing works

Uncontrolled diabetes increases the risk of Alzheimer’s disease: a population-based cohort study

Xu, W. L., von Strauss, E., Qiu, C. X., Winblad, B., & Fratiglioni, L. (2009) · Diabetologia · doi:10.1007/s00125-009-1323-x · Cited by 272 · see citing works

Review of Medical Microbiology and Immunology

Levinson, W. E. (2002) · Repository of the University of Ljubljana (University of Ljubljana) · Cited by 256 · see citing works

The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection

Stecher, B. (2015) · Microbiology Spectrum · doi:10.1128/microbiolspec.mbp-0008-2014 · Cited by 235 · see citing works

Interactions of innate and adaptive immunity in brain development and function

Filiano, A. J., Gadani, S. P., & Kipnis, J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.07.050 · Cited by 217 · see citing works

Amyloidosis and Alzheimer’s disease

Ghiso, J. A., & Frangione, B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00149-7 · Cited by 189 · see citing works

Inflammation and gut-brain axis link obesity to cognitive dysfunction: plausible pharmacological interventions

Solas, M., Milagro, F. I., Ramírez, M. J., & Martínez, J. A. (2017) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2017.10.005 · Cited by 173 · see citing works

Neuroprotective properties of GLP-1: theoretical and practical applications

Holst, J. J., Burcelin, R., & Nathanson, E. (2011) · Current Medical Research and Opinion · doi:10.1185/03007995.2010.549466 · Cited by 152 · see citing works

Chicoric acid supplementation prevents systemic inflammation‐induced memory impairment and amyloidogenesis via inhibition of NF‐κB

Liu, Q., Chen, Y., Shen, C., Xiao, Y., Wang, Y., Liu, Z., & Liu, X. (2016) · The FASEB Journal · doi:10.1096/fj.201601071r · Cited by 146 · see citing works

Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?

Esteve, E., Ricart, W., & Fernández-Real, J.-M. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e328348c06d · Cited by 133 · see citing works

Enhancing Central Nervous System Endogenous GLP-1 Receptor Pathways for Intervention in Alzheimers Disease

Perry, T., & Greig, N. (2005) · Current Alzheimer Research · doi:10.2174/1567205054367892 · Cited by 127 · see citing works

Glucagon-like peptides 1 and 2 in health and disease: A review

Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M. (2013) · Peptides · doi:10.1016/j.peptides.2013.01.014 · Cited by 100 · see citing works

New roles for insulin-like hormones in neuronal signalling and protection: New hopes for novel treatments of Alzheimer’s disease?

Hölscher, C., & Li, L. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.08.023 · Cited by 93 · see citing works

Reclamation of Chinese herb residues using probiotics and evaluation of their beneficial effect on pathogen infection

Meng, F., Yang, S., Wang, X., Chen, T., Wang, X., Tang, X., Zhang, R., & Shen, L. (2017) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2016.11.013 · Cited by 89 · see citing works

Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis

Lee, M., McGeer, E. G., & McGeer, P. L. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.024 · Cited by 83 · see citing works

The intricate association between gut microbiota and development of Type 1, Type 2 and Type 3 diabetes

Bekkering, P., Jafri, I., van Overveld, F. J., & Rijkers, G. T. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.848793 · Cited by 77 · see citing works

ApoE genotype is a risk factor in nonpresenilin early-onset alzheimer's disease families

Houlden, H., Crook, R., Backhovens, H., Prihar, G., Baker, M. C., Hutton, M., Rossor, M. N., Martin, J. J., Broeckhoven, C. V., & Hardy, J. (1998) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19980207)81:1 · Cited by 64 · see citing works

Consumption of a high-fat diet alters the seminal fluid and gut microbiomes in male mice

Javurek, A. B., Spollen, W. G., Johnson, S., Bivens, N. J., Bromert, K. H., Givan, S. A., & Rosenfeld, C. S. (2016) · Reproduction Fertility and Development · doi:10.1071/rd16119 · Cited by 52 · see citing works

Anti-cancer and Sensibilisation Effect of Triptolide on Human Epithelial Ovarian Cancer

Hu, H., Luo, L., Liu, F., Zou, D., Zhu, S., Tan, B., & Chen, T. (2016) · Journal of Cancer · doi:10.7150/jca.16178 · Cited by 49 · see citing works

Hedgehog signaling pathway regulates ovarian cancer invasion and migration via adhesion molecule CD24

Zeng, C., Chen, T., Zhang, Y., & Chen, Q. (2017) · Journal of Cancer · doi:10.7150/jca.17712 · Cited by 45 · see citing works

Evaluation of the accuracy and sensitivity of high‑throughput sequencing technology using known microbiota

Meng, F., Chen, T., Wang, X., Wang, X., Wei, H., Tian, P., Wang, H., Zhao, X., Shen, L., & Xin, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7849 · Cited by 15 · see citing works

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298 · see citing works

The Gut–Brain Axis and Its Relation to Parkinson’s Disease: A Review

Klann, E. M., Dissanayake, U., Gurrala, A., Farrer, M. J., Shukla, A. W., Ramirez‐Zamora, A., Mai, V., & Vedam‐Mai, V. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.782082 · Cited by 191 · see citing works

Engineering probiotics for therapeutic applications: recent examples and translational outlook

Aggarwal, N., Breedon, A. M. E., Davis, C. M., Hwang, I. Y., & Chang, M. W. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.02.016 · Cited by 158 · see citing works

Next-generation probiotics: a promising approach towards designing personalized medicine

Singh, T. P., & Nataraj, B. H. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1902940 · Cited by 145 · see citing works

GLP-1’s role in neuroprotection: a systematic review

Erbil, D., Eren, C. Y., Demirel, Ç., Küçüker, M. U., Solaroğlu, İ., & Eser, H. Y. (2019) · Brain Injury · doi:10.1080/02699052.2019.1587000 · Cited by 128 · see citing works

Psychobiotics: the Influence of Gut Microbiota on the Gut-Brain Axis in Neurological Disorders

Oroojzadeh, P., Bostanabad, S. Y., & Lotfi, H. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02053-3 · Cited by 105 · see citing works

A randomised trial of probiotics to reduce severity of physiological and microbial disorders induced by partial gastrectomy for patients with gastric cancer

Zheng, C., Chen, T., Wang, Y., Gao, Y., Kong, Y., Liu, Z., & Deng, X. (2019) · Journal of Cancer · doi:10.7150/jca.29072 · Cited by 93 · see citing works

Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1

Paternoster, S., & Falasca, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00584 · Cited by 91 · see citing works

Neuroprotective effects of an engineered commensal bacterium in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine Parkinson disease mouse model via producing glucagon‐like peptide‐1

Fang, X., Tian, P., Zhao, X., Jiang, C., & Chen, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14694 · Cited by 72 · see citing works

Engineered microbial systems for advanced drug delivery

Shen, H., Aggarwal, N., Wun, K. S., Lee, Y. S., Hwang, I. Y., & Chang, M. W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114364 · Cited by 72 · see citing works

Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease

Fang, X., Zhou, X., Miao, Y., Han, Y., Wei, J., & Chen, T. (2020) · AMB Express · doi:10.1186/s13568-020-01014-6 · Cited by 70 · see citing works

Neurotrophic Role of the Next-Generation Probiotic Strain L. lactis MG1363-pMG36e-GLP-1 on Parkinson’s Disease via Inhibiting Ferroptosis

Yue, M., Wei, J., Chen, W., Hong, D., Chen, T., & Fang, X. (2022) · Nutrients · doi:10.3390/nu14224886 · Cited by 62 · see citing works

Adjuvant treatment and molecular mechanism of probiotic compounds in patients with gastric cancer after gastrectomy

Zheng, C., Chen, T., Lu, J., Wei, K., Tian, H., Liu, W., Tian, X., Wang, X., Wang, S., Yang, R. L., et al. (2021) · Food & Function · doi:10.1039/d1fo01375k · Cited by 59 · see citing works

Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP ‐1 and modulating gut microbiota

Wu, H., Wei, J., Zhao, X., Liu, Y., Chen, Z., Wei, K., Lu, J., Chen, W., Jiang, M., Li, S., et al. (2022) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10351 · Cited by 57 · see citing works

GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASH

Li, Q.-X., Gao, H., Guo, Y.-X., Wang, B.-Y., Hua, R.-X., Gao, L., Shang, H.-W., Lu, X., & Xu, J.-D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721198 · Cited by 56 · see citing works

The pleiotropic of GLP-1/GLP-1R axis in central nervous system diseases

Zhang, L., Zhang, W., & Tian, X. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2021.1924707 · Cited by 54 · see citing works

Genetically Engineered Escherichia coli Nissle 1917 Secreting GLP‐1 Analog Exhibits Potential Antiobesity Effect in High‐Fat Diet‐Induced Obesity Mice

Ma, J., Li, C., Wang, J., & Gu, J. (2020) · Obesity · doi:10.1002/oby.22700 · Cited by 53 · see citing works

Engineered probiotics Clostridium butyricum ‐pMTL007‐GLP ‐1 improves blood pressure via producing GLP ‐1 and modulating gut microbiota in spontaneous hypertension rat models

Wang, X., Chen, W., Jin, R., Xu, X., Wei, J., Huang, H., Tang, Y., Zou, C., & Chen, T. (2022) · Microbial Biotechnology · doi:10.1111/1751-7915.14196 · Cited by 46 · see citing works

Oncolytic Bacteria and their potential role in bacterium-mediated tumour therapy: a conceptual analysis

Wang, Y., Guo, W., Wu, X., Zhang, Y., Mannion, C. M., Brouchkov, A. V., Man, Y.-G., & Chen, T. (2019) · Journal of Cancer · doi:10.7150/jca.35648 · Cited by 42 · see citing works

Anti-aging effect of the combination of Bifidobacterium longum and B. animalis in a d-galactose-treated mice

Xia, C., Cao, X., Cui, L., Liu, H., Wang, S., & Chen, T. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.103938 · Cited by 42 · see citing works

Engineered Bacteria of MG1363-pMG36e-GLP-1 Attenuated Obesity-Induced by High Fat Diet in Mice

Wang, L., Chen, T., Wang, H., Wu, X., Cao, Q. N., Wen, K., Deng, K., & Xin, H. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.595575 · Cited by 40 · see citing works

Improvement effect of a next-generation probiotic L. plantarum -pMG36e-GLP-1 on type 2 diabetes mellitus via the gut–pancreas–liver axis

Hu, H., Luo, J., Liu, Y., Li, H., Jin, R., Li, S., Wei, J., Hong Kui, W. E. I., & Chen, T. (2023) · Food & Function · doi:10.1039/d3fo00044c · Cited by 34 · see citing works

Antidiabetic effect of an engineered bacterium Lactobacillus plantarum-pMG36e -GLP-1 in monkey model

Luo, J., Zhang, H., Lu, J., Ma, C., & Chen, T. (2021) · Synthetic and Systems Biotechnology · doi:10.1016/j.synbio.2021.09.009 · Cited by 32 · see citing works

Health benefits, antimicrobial activities, and potential applications of probiotics: A review

Sepehr, A., Miri, S. T., Aghamohammad, S., Rahimirad, N., Milani, M., Pourshafie, M. R., & Rohani, M. (2024) · Medicine · doi:10.1097/md.0000000000032412 · Cited by 32 · see citing works

Gut microbiota: Candidates for a novel strategy for ameliorating sleep disorders

Li, L., Liang, T., Jiang, T., Li, Y., Yang, L., Wu, L., Yang, J., Ding, Y., Wang, J., Chen, M., et al. (2023) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2023.2228409 · Cited by 30 · see citing works

Advanced microbiome therapeutics for oral delivery of peptides and proteins: Advances, challenges, and opportunities

Gelli, H. P., Vazquez-Uribe, R., Buckley, S. T., Andersen, J. T., & Sommer, M. O. A. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115603 · Cited by 28 · see citing works

The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment

Sun, H., Hao, Y., Liu, H., & Gao, F. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1525623 · Cited by 25 · see citing works

Peptide GLP-1 receptor agonists: From injection to oral delivery strategies

Ke, Z., Ma, Q., Ye, X., Wang, Y., Jin, Y., Zhao, X., & Su, Z. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116471 · Cited by 24 · see citing works

Treatment with a probiotic combination reduces abdominal adhesion in rats by decreasing intestinal inflammation and restoring microbial composition

Deng, X., Zheng, C., Wang, S., Yang, R. L., Liu, Z., & Chen, T. (2020) · Oncology Reports · doi:10.3892/or.2020.7463 · Cited by 23 · see citing works

Gut Microbiota-Based Interventions for Parkinson’s Disease: Neuroprotective Mechanisms and Current Perspective

Kumar, D., Bishnoi, M., Kondepudi, K. K., & Sharma, S. S. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10433-x · Cited by 21 · see citing works

Attenuated Salmonella engineered with an apoptosis-inducing factor (AIF) eukaryotic expressing system enhances its anti-tumor effect in melanoma in vitro and in vivo

Wang, H., Chen, T., Wan, L., Lu, J., Wei, H., Deng, K., Wei, J., & Xin, H. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10485-3 · Cited by 21 · see citing works

Modified probiotics and the related combinatorial therapeutics

Zhao, L., Niu, M., Ma, Z., He, F., Liu, X., Gong, X., Chai, Z., Wang, Z., Feng, Q., & Wang, L. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.03.021 · Cited by 20 · see citing works

GLP-1 as a regulator of sepsis outcomes: Insights into cellular metabolism, inflammation, and therapeutic potential

Fan, W., Zhang, Q., Wang, C., Sun, J., Zhang, J., & Yin, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114390 · Cited by 12 · see citing works

Importance of microbial amphiphiles: interaction potential of biosurfactants, amyloids, and other exo-polymeric-substances

Master, N. G., & Markande, A. R. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03751-9 · Cited by 11 · see citing works

Evaluation of Sodium Hypochlorite Irrigant, Bingpeng Irrigant, and Fufang Bingpeng Irrigant as Endodontic Irrigants During Passive Ultrasonic Irrigation

Shi, Y., Deng, Z., Yang, Y., Cui, L., Chen, T., Hu, M., Xie, L., & Yang, J. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00145 · Cited by 11 · see citing works

Engineered probiotics introduced to improve intestinal microecology for the treatment of chronic diseases: present state and perspectives

Guo, J., Zhou, B., Niu, Y., Liu, L., & Yang, L. (2023) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-023-01279-1 · Cited by 10 · see citing works

Neuroprotection in Parkinson Disease

Gonzalez‐Robles, C., Bandmann, O., & Schapira, A. H. V. (2025) · Neurology and Therapy · doi:10.1007/s40120-025-00793-z · Cited by 11 · see citing works

Potential applications of engineered bacteria in disease diagnosis and treatment

Luo, Z., Qi, Z., Luo, J., & Chen, T. (2024) · Microbiome Research Reports · doi:10.20517/mrr.2024.57 · Cited by 9 · see citing works

Bacterial and bacterial derivatives-based drug delivery systems: a novel approach for treating central nervous system disorders

Gao, S., Li, X., & Han, B. (2024) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2024.2444364 · Cited by 7 · see citing works

From lab to law: emerging applications, potential benefits, evolving regulatory framework and challenges for engineered probiotics

Pierro, F. D., Thacharodi, A., Kumaraswami, M., Suvorov, A. N., Zupet, J., & Zerbinati, N. (2026) · Microbial Cell Factories · doi:10.1186/s12934-026-02997-w · Cited by 8 · see citing works

Microbiota–gut–brain axis and related therapeutics in Alzheimer’s disease: prospects for multitherapy and inflammation control

Li, J., Zhang, F., Zhao, L., & Dong, C. (2023) · Reviews in the Neurosciences · doi:10.1515/revneuro-2023-0006 · Cited by 6 · see citing works

Engineered Bacteria as Living Materials for Oral Delivery of Peptide Drugs

Yu, L. J., Han, X., Liu, J., Yan, X., & Li, T. F. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6c06551 · Cited by 5 · see citing works

Oral Administration of Bacterial β Cell Expansion Factor A (BefA) Alleviates Diabetes in Mice with Type 1 and Type 2 Diabetes

Wang, H., Wei, J., Hu, H., Le, F., Wu, H., Wei, H., Luo, J., & Chen, T. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/9206039 · Cited by 4 · see citing works

The engineered probiotics for the treatment of chronic diseases: A systematic review

Barati, M., Jabbari, M., Ghavidel, A. A., Nikmehr, P., Arzhang, P., Aynehchi, A., Babashahi, M., Mosharkesh, E., Roshanravan, N., Shabani, M., et al. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14343 · Cited by 4 · see citing works

Gut Microbiota Modification via Glucagon-like Peptide-1 with Beneficial Neuroprotective Effects

Sayehmiri, F., Samadian, M. M., Mohamadkhani, A., Tafakhori, A., Haghighat, S., Rahmatian, A., Mohammadkhani, M. A., Fazli, H. R., & Rezaei–Tavirani, M. (2022) · Middle East Journal of Digestive Diseases · doi:10.34172/mejdd.2022.278 · Cited by 4 · see citing works

Understanding the neurobiological mechanisms of LPS‑induced memory impairment

Golkar, A., Dalfardi, M., Hedayati‐Moghadam, M., Askarpour, H., Hosseini, M., & Baghcheghi, Y. (2025) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2024-2629 · Cited by 2 · see citing works

Revealing gut microbiota metabolism with dietary glycan-fluorophore conjugates

Altamura, F. (2019) · eScholarship@McGill (McGill) · doi:10.82308/45005

Engineered bacteria: a novel era for metabolic, cardiovascular and cerebrovascular diseases therapy

Wu, Y., Sang, R., Chen, X., & Wang, S. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1757348

Persistent prostaglandin E2 upregulation and hormonal multi-resistance: A hypothesis for long COVID

Ramer, V., & van Montfrans, G. A. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102518

Neuroprotection of engineered Clostridium butyricum-pMTL007-GLP-1 in A53T α-synuclein (α-syn) mouse model via PI3K/AKT/GSK-3β

Fang, X., Wang, Y., Long, Z., Liao, B., Wang, B., Hong, D., Luo, J., & Chen, T. (2026) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2500237

Neuroinflammation in Alzheimer’s disease-associated sensory dysfunction: mechanistic links, actionable targets and therapeutic strategies

Xu, Y., Zhang, G., Cui, X., & Sun, L. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1838634

Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease

Fang, X., Zhou, X., Miao, Y., Han, Y., Wei, J., & Chen, T. (2020) · AMB Express · doi:10.1186/s13568-020-01014-6 · Cited by 70 · see citing works

Glucagon‐like peptide‐1 protects synaptic and learning functions from neuroinflammation in rodents

Iwai, T., Sawabe, T., Tanimitsu, K., Suzuki, M., Sasaki‐Hamada, S., & Oka, J. (2014) · Journal of Neuroscience Research · doi:10.1002/jnr.23335 · Cited by 51 · see citing works

Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure

Yoon, G., Kim, Y., & Song, J. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104615 · Cited by 109 · see citing works

Regulation of neuroinflammation with GLP-1 receptor targeting nanostructures to alleviate Alzheimer’s symptoms in the disease models

Zhao, Y., Tian, S., Zhang, J., Cheng, X., Huang, W., Cao, G., Chang, Y., Wang, H., Nie, G., & Qiu, W. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101457 · Cited by 23 · see citing works

Semaglutide Ameliorates Neuroinflammation Caused by Enterogenous Pyrogen in APP/PS1 MicePreprint

Yuan, Y., Zhang, J., Zhang, Z., Zhai, Y., Cheng, X., Xue, L., Zhao, F. L., Cao, L. H., & Wang, H. (2025) · Research Square · doi:10.21203/rs.3.rs-6098406/v1 · Cited by 1 · see citing works